Pages that link to "Q36585738"
Jump to navigation
Jump to search
The following pages link to Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls (Q36585738):
Displaying 50 items.
- The amyloid hypothesis of Alzheimer's disease at 25 years (Q26749528) (← links)
- Tibetan medicine "RNSP" in treatment of Alzheimer disease (Q26765304) (← links)
- Expanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted Approaches (Q26770708) (← links)
- Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics (Q26784569) (← links)
- Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics (Q26822002) (← links)
- Applications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseases (Q26860077) (← links)
- Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease (Q27003841) (← links)
- Three dimensions of the amyloid hypothesis: time, space and 'wingmen' (Q28082768) (← links)
- Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunities (Q28087158) (← links)
- Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's disease (Q28542628) (← links)
- Imbalance in fatty-acid-chain length of gangliosides triggers Alzheimer amyloid deposition in the precuneus (Q28544853) (← links)
- Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits (Q28544876) (← links)
- Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity (Q29465470) (← links)
- Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid (Q30842997) (← links)
- A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles (Q33596318) (← links)
- 16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain (Q33813209) (← links)
- Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes (Q34031193) (← links)
- The intersection of amyloid beta and tau at synapses in Alzheimer's disease (Q34054680) (← links)
- Amyloid-beta: a crucial factor in Alzheimer's disease. (Q34451907) (← links)
- Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients (Q34470414) (← links)
- Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer's disease (Q34538592) (← links)
- Disruption of amyloid plaques integrity affects the soluble oligomers content from Alzheimer disease brains (Q34654255) (← links)
- Emerging technologies to increase ligand binding assay sensitivity (Q34871754) (← links)
- Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques (Q35030015) (← links)
- Immobilization of homogeneous monomeric, oligomeric and fibrillar Aβ species for reliable SPR measurements (Q35110767) (← links)
- Improvement of memory deficits and amyloid-β clearance in aged APP23 mice treated with a combination of anti-amyloid-β antibody and LXR agonist (Q35137114) (← links)
- A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid (Q35206591) (← links)
- Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis (Q35327172) (← links)
- The pathophysiology of repetitive concussive traumatic brain injury in experimental models; new developments and open questions (Q35706415) (← links)
- Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models. (Q35837187) (← links)
- Multiplexed In-cell Immunoassay for Same-sample Protein Expression Profiling. (Q36017933) (← links)
- The aqueous phase of Alzheimer's disease brain contains assemblies built from ∼4 and ∼7 kDa Aβ species. (Q36119212) (← links)
- Systematic analysis of time-dependent neural effects of soluble amyloid β oligomers in culture and in vivo: Prevention by scyllo-inositol (Q36269014) (← links)
- Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases (Q36468755) (← links)
- Advances in the development of vaccines for Alzheimer's disease (Q36965988) (← links)
- A Luminex assay detects amyloid β oligomers in Alzheimer's disease cerebrospinal fluid (Q36976390) (← links)
- Redundant Gs-coupled serotonin receptors regulate amyloid-β metabolism in vivo (Q37018138) (← links)
- Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology (Q37043088) (← links)
- Soluble Amyloid-beta Aggregates from Human Alzheimer's Disease Brains (Q37472307) (← links)
- Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease (Q37577892) (← links)
- Amyloid β-protein oligomers and Alzheimer's disease (Q37690332) (← links)
- Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians (Q37693146) (← links)
- Biomarker modelling of early molecular changes in Alzheimer's disease (Q38166669) (← links)
- Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease. (Q38185153) (← links)
- Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer's disease (Q38240609) (← links)
- The role of glial cells and the complement system in retinal diseases and Alzheimer's disease: common neural degeneration mechanisms. (Q38245648) (← links)
- Toxic species in amyloid disorders: Oligomers or mature fibrils (Q38505323) (← links)
- Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease (Q38590807) (← links)
- Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease. (Q38619618) (← links)
- A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. (Q38779102) (← links)